GIM
BSX icon

Generali Investments Management’s Boston Scientific BSX Stock Holding History

Generali Investments Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
48,040
+18,566
+63% +$1.01M 0.45% 50
2026
Q1 		$1.85M Sell
29,474
-9,263
-24% -$741K 0.43% 50
2025
Q4 		$3.69M Sell
38,737
-3,456
-8% -$339K 0.74% 29
2025
Q3 		$4.12M Buy
42,193
+2,135
+5% +$221K 0.86% 21
2025
Q2 		$4.3M Buy
40,058
+9,146
+30% +$925K 0.97% 25
2025
Q1 		$3.12M Buy
30,912
+3,886
+14% +$391K 0.89% 29
2024
Q4 		$2.41M Buy
+27,026
New +$2.38M 0.62% 41

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Generali Investments Management's BSX Position: Q2 2026 in Review

Generali Investments Management increased its Boston Scientific (BSX) stake by 63% in Q2 2026, buying an estimated $1.01M and bringing the position to 48,040 shares worth $2.05M. The position accounts for 0.45% of the portfolio, ranked #50.

Generali Investments Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.3M in Q2 2025. 267 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Generali Investments Management held 48,040 shares of Boston Scientific worth $2.05M as of Q2 2026.
  • Generali Investments Management bought 18,566 Boston Scientific shares in Q2 2026, an estimated $1.01M.
  • Boston Scientific made up 0.45% of Generali Investments Management's portfolio in Q2 2026, its #50 holding.
  • Generali Investments Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Boston Scientific position peaked at $4.3M in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.